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Penelope Austin* and Miranda RobertsonThe central principle of open access is to make the
results of research freely available to all, and as a pioneer
of this model of scientific publishing, BioMed Central
has always recognised that realising the full value of this
accessibility depends on transparent reporting of the
experimental work, as well as making the data available
for others to analyze and re-use. This general principle
is stated in our guide to authors, while referees who
assess our research articles are asked to consider
whether the methods are adequately reported, whether
the data shown include the necessary controls and are
adequate to support the conclusions drawn, and whether
they have been able to assess the validity of the statistics.
Authors and reviewers are also pointed to various
internet-hosted reporting checklists relevant to different
types of research.
There is arguably a need for more, however. In the
wake of recent concern about the unreliability and irre-
producibility of a significant proportion of published
preclinical research [1, 2], the risk of a consequent loss
of public trust, and the waste when such research is used
as a basis for costly clinical trials, both the publishers
and funders of biomedical research have recognised the
need to impose reporting standards. One outcome has
been the publication of principles and guidelines for
reporting preclinical research by the NIH [3] along with
a call for the use of checklists by endorsing journals, in a
bid to raise consciousness and standards in this area,
and facilitate the interpretation and repetition of pub-
lished work.
From this month four Biomed Central journals —
BMC Biology, BMC Neuroscience, Genome Biology and
GigaScience — will pilot the use of a checklist for our
submitting authors [4]. This short set of guidelines
reflects four central requirements in accordance with
BioMed Central’s general commitment to full and trans-
parent reporting, and with the principles set out by the
NIH. First is the need for transparency, so that, for* Correspondence: Penelope.austin@biomedcentral.com
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available in this article, unless otherwise staexample, the number of replicates is clearly stated and
biological and technical replicates can be distinguished.
Second, the importance of appropriate statistical ana-
lysis. Third, a requirement for the reagents used,
such as antibodies, to be unambiguously identified.
Fourth, that the data and materials on which the
conclusions of published work rely should be made
available.
The difficulties of attempting a set of requirements
that are not too dogmatic or unduly burdensome and
are appropriate to the wide range of research we publish
should not be underestimated, and there are arguably
dangers in constraining all research to standards best ap-
plied to established fields and well defined systems. In
developing our checklist, we have benefited both from
the experience of authors with the checklists of other
journals and from the advice of our Editorial Board, a
selection of whose comments can be found in our
blog [5].
With the aim of not overburdening submitting authors
whose papers meet the standards set, we do not ask for
page and line numbers for each piece of information,
but instead for confirmation that applicable require-
ments have been met, and/or for explanations where this
has not been fully achieved. The checklist and authors’
answers in reference to it will play a part in our editorial
assessment of whether a paper should be sent for peer
review, and help avoid the situation where reviewers are
hindered in their ability to assess a paper because infor-
mation is missing. Reviewers will also see the authors’
answers and be able to advise us whether they are
acceptable or not.
During the pilot phase for the checklist, we shall be
collecting feedback and monitoring the effects on the
transparency of submissions and the reports of our
referees, with a view to striking a sensible balance
between enforcing rigor and impeding progress.
Of course a checklist cannot itself guarantee reprodu-
cibility. By insisting on transparency it should make clear
the degree to which the conclusions of each publishedThis article is distributed under the terms of the Creative Commons
creativecommons.org/licenses/by/4.0), which permits unrestricted use,
um, provided you give appropriate credit to the original author(s) and the
ons license, and indicate if changes were made. The Creative Commons
eativecommons.org/publicdomain/zero/1.0/) applies to the data made
ted.
Austin and Robertson BMC Biology  (2015) 13:59 Page 2 of 2study have been rigorously tested, but this does not rule
out the possibility that subsequent studies may call
these conclusions into question, and in such cases
we recognize the obligation to publish a convincing
rebuttal.
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